¹û¶³Ó°Ôº

XClose

¹û¶³Ó°Ôº Module Catalogue

Home
Menu

Pharmaceutical and Biotech Policies and Practices (GBSH0023)

Key information

Faculty
Faculty of Population Health Sciences
Teaching department
Global Business School for Health
Credit value
15
Restrictions
This module is only available for ¹û¶³Ó°Ôº Global Business School for Health students.
Timetable

Alternative credit options

There are no alternative credit options available for this module.

Description

The aim of this module is to provide you with insights into biotechnology and pharmacology practices and strategies for research and development management; business maintenance and expansion; licensing; generic versus brand-name proprietary drug business; and mergers and acquisitions as these topics relate to these industries.

You will learn specifically about pharmaceutical expenditures, pricing of drugs and the distinctive features of the pharmaceutical market due to drug funding policies. ÌýYou will also understand the advantages and disadvantages of various models of drug price setting and regulation that are applied in various health systems.Ìý

Patents, intellectual property and ethics will be evaluated for both industries with the aim of analysing the main economic and societal effects and perceptions.

Module deliveries for 2024/25 academic year

Intended teaching term: Term 1 ÌýÌýÌý Postgraduate (FHEQ Level 7)

Teaching and assessment

Mode of study
In person
Intended teaching location
¹û¶³Ó°Ôº East
Methods of assessment
40% Other form of assessment
60% Coursework
Mark scheme
Numeric Marks

Other information

Number of students on module in previous year
124
Module leader
Dr Radi Haloub
Who to contact for more information
educationgbsh@ucl.ac.uk

Last updated

This module description was last updated on 8th April 2024.

Ìý